Escapelle 1500 microgram tablet(Postinor)
Levonorgestrel
Escapelle 1500 microgram tablet and Postinor are different trade names for the same medicine.
important information for the patient.
Escapelle 1500 is an emergency contraceptive method that can be used within 72 hours (3 days) after unprotected sex or when a contraceptive method has failed. This includes the following situations:
Escapelle 1500 contains a synthetic hormone called levonorgestrel as an active substance.
This medicine, taken within 72 hours after unprotected sex, prevents pregnancy in 84%. It will not prevent pregnancy in every case, and its effectiveness is greater if taken as soon as possible after unprotected sex. It is best to take the medicine within the first 12 hours, rather than waiting until the third day after unprotected sex.
It is thought that Escapelle 1500 works by:
Escapelle 1500 prevents pregnancy only if taken within 72 hours after unprotected sex. This medicine is not effective if the patient is already pregnant.
If unprotected sex occurs after taking Escapelle 1500 (also during the same menstrual cycle), the tablet may not work as a contraceptive, and there may be a risk of pregnancy again.
Escapelle 1500 is not indicated for use before the first menstrual bleeding (menarche).
If any of the following points apply to the patient, they should inform their doctor before taking Escapelle 1500, as emergency contraception may not be suitable for the patient. The doctor may prescribe a different type of emergency contraception (after unprotected sex), such as a copper intrauterine device (Cu-IUD).
It is not recommended to take Escapelle 1500 if:
A history of ectopic pregnancy or fallopian tube inflammation increases the risk of another ectopic pregnancy.
All women should use emergency contraception as soon as possible after unprotected sex. There is evidence that Escapelle 1500 may be less effective with increasing body weight or body mass index (BMI), but the data are limited and inconclusive. Therefore, Escapelle 1500 is still recommended for all women, regardless of their body weight or BMI.
In case of any doubts about emergency contraception, the patient should consult a doctor, pharmacist, or nurse.
Escapelle 1500 is not indicated for use before the first menstrual bleeding (menarche).
If a condom was not used during sex (or was damaged or slipped), the patient may have been infected with a sexually transmitted disease or HIV.
This medicine does not protect against sexually transmitted diseases. Only the use of condoms can protect against infection. In case of doubts, the patient should consult a doctor, nurse, family planning specialist, or pharmacist.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Some medicines may reduce the effectiveness of Escapelle 1500. If the patient has taken any of the following medicines in the last 4 weeks, Escapelle 1500 may not be suitable for them. The doctor may prescribe a different type (non-hormonal) of emergency contraception (after unprotected sex), such as a copper intrauterine device (Cu-IUD). If this is not the case for the patient or the patient cannot see a doctor immediately, they can take a double dose of Escapelle 1500 (i.e., 2 tablets at the same time):
To get more information about the correct dose, the patient should contact their doctor or pharmacist.
After taking the tablets to get further advice on regular contraception and to rule out pregnancy, the patient should contact their doctor or pharmacist as soon as possible (see also section 3 "How to take Escapelle 1500").
Escapelle 1500 may also affect the action of other medicines:
Escapelle 1500 should only be taken in emergency situations and not as a regular contraceptive method. If Escapelle 1500 is taken more than once in the same menstrual cycle, its contraceptive effect is weaker, and the risk of menstrual cycle disorders (menstruation) is higher.
Escapelle 1500 is not as effective as regular contraceptive methods. To get information about long-term contraceptive methods that are more effective in preventing pregnancy, the patient should consult a doctor, nurse, or family planning specialist.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
Pregnant women should not take this medicine. If the patient becomes pregnant despite taking Escapelle 1500, it is essential that they consult their doctor. There is no evidence that Escapelle 1500 has a harmful effect on the developing fetus if the patient takes Escapelle 1500 according to the instructions. However, the doctor will want to check that it is not an ectopic pregnancy (when the embryo develops outside the uterus). This is especially important if the patient experiences severe abdominal pain after taking Escapelle 1500 or if they have had an ectopic pregnancy, undergone fallopian tube surgery, or had pelvic inflammatory disease.
Breastfeeding
The active substance of this medicine passes into breast milk. It is recommended that the patient takes the tablet immediately after breastfeeding and then avoids breastfeeding for at least 8 hours after taking levonorgestrel and expresses milk from the breast using a breast pump for 8 hours after taking the tablet. By taking the tablet much earlier before the next breastfeeding, the amount of active substance that could pass into the baby's body through breast milk can be reduced.
Fertility
Taking Escapelle 1500 increases the possibility of menstrual disorders, which can sometimes lead to delayed or accelerated ovulation, affecting the fertility period. Since there is no data on the long-term effect on fertility, after taking Escapelle 1500, the patient should expect a quick return to fertility.
Therefore, after taking Escapelle 1500, the patient should continue to use regular contraception or start using it as soon as possible.
It is unlikely that Escapelle 1500 will affect the ability to drive or use machines. However, if the patient feels tired or dizzy, they should not drive or use machines.
In cases of intolerance to some sugars, note that one Escapelle 1500 tablet contains 142.5 mg of lactose monohydrate.
If the patient has been diagnosed with an intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine should always be taken according to the doctor's instructions. In case of doubts, the patient should consult their doctor or pharmacist.
The tablet should be taken as soon as possible, preferably within 12 hours, and no later than 72 hours (3 days) after unprotected sex. The patient should not delay taking the tablet. The sooner the tablet is taken after unprotected sex, the more effective it is. The tablet can only prevent pregnancy if taken within 72 hours after unprotected sex.
If the patient has another unprotected sex (also during the same menstrual cycle) after taking the Escapelle 1500 tablet, the tablet will not have a contraceptive effect, and there is a risk of pregnancy again.
In case of any doubts about emergency contraception, the patient should consult a doctor, pharmacist, or nurse.
If vomiting occurs within 3 hours of taking the tablet, the patient should take another tablet immediately.
If the patient is not taking contraceptive pills and plans to have sex after taking Escapelle 1500, they should use condoms or a diaphragm with spermicides until the next menstrual period. This is necessary because Escapelle 1500 is not effective in case of another unprotected sex before the next scheduled menstrual period.
About 3 weeks after taking Escapelle 1500, the patient is advised to have a medical check-up to ensure that the medicine has worked. If menstrual bleeding is delayed by more than 5 days or is unusual, the patient should consult their doctor as soon as possible. If the patient becomes pregnant despite taking Escapelle 1500, it is essential that they consult their doctor.
The doctor may also provide information about long-term contraceptive methods that are more effective in preventing pregnancy.
If the patient continues to take regular hormonal contraception, such as contraceptive pills, and does not experience menstrual bleeding during the pill-free period, they should consult their doctor to rule out pregnancy.
After taking Escapelle 1500, menstrual bleeding is usually normal and starts on the same day as usual, but it may occur a few days later or earlier. The patient may also experience irregular bleeding or spotting. If menstrual bleeding is delayed by more than 5 days, or is unusual, the patient should consult their doctor as soon as possible.
Although no serious side effects have been reported when taking a large number of tablets at the same time, nausea, vomiting, and bleeding from the genital tract may occur. The patient should consult a pharmacist, doctor, nurse, or family planning specialist, especially if vomiting occurs, as the tablet may not work.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If the patient experiences any side effects, including any not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Store in the original packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The tablet is almost white, flat, with a diameter of about 8 mm, with the inscription "G00" on one side.
Packaging: one tablet in a PVC/Aluminum blister pack and a cardboard box.
To get more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Gedeon Richter Plc.
Gyömrői út 19-21.
1103 Budapest
Hungary
Gedeon Richter Plc.
Gyömrői út 19-21.
1103 Budapest
Hungary
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Belgium, the country of export:BE285196
Austria: Postinor
Belgium: Postinor
France: Levonorgestrel Biogaran
Greece: Postinor
Spain: Postinor
Netherlands: Postinor
Ireland: Ramonna
Iceland: Postinor
Lithuania: Escapelle
Luxembourg: Postinor
Germany: Postinor
Norway: Postinor
Poland: Escapelle 1500 microgram tablet
Portugal: Postinor
Czech Republic: Escapelle
Sweden: Postinor
Italy: Escapelle
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.